Overall, 94% of SQCCs expressed SOX2, with most tumor cells expressing moderate to high levels, and 73% had detectable levels of SOX9, although in the majority of cases SOX9 was expressed in very few tumor cells and at low levels (S8A and S8B Fig, Table 1). This evidence concerns the gene SOX2 and neoplasm.